Barrington James has a true global reach, with its international HQ in London-Gatwick, continental hubs in Singapore, North Carolina, and New York, and further offices in Germany, Kuala Lumpur and Hong Kong.
The company specialises in recruitment within the Pharmaceutical, Medical Devices and Healthcare cluster of industries and nothing else. Within this group, individual consultants and teams specialize vertically into specific market sectors or functions, and are thus experts in their field.
Bionow supports business growth, competitiveness and innovation within the biomedical and life science sectors across Northern England. Our membership services add value and cost-efficiency to scientific, clinical and business operations within early stage and growth-oriented firms. Our membership base includes startups and early stage firms as well as established growth-oriented companies. Bionow's membership offering focuses upon the specific needs of firms at their different stages of development, including dedicated business support programmes, shared procurement schemes with significant cost savings, exclusive insurance benefits, recruitment and training services, local and national events and access to a vibrant network of businesses.
BioPartner UK leads the UK Delegation to several partnering conferences each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.
BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.
Britannia Pharmaceuticals, part of the STADA group, is a UK based pharmaceutical company. We specialise in innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease. Our key product Apomorphine Hydrochloride (Brand names: APO-go, APOKYN, Apomine) is a treatment for Parkinson’s disease which is available in many markets through our Distribution or Licensing Partners. Additionally we have developed non-opiate based therapeutics to assist in opiate detoxification and withdrawal. We are actively looking to in-license marketed products for the UK, other parts of Europe and even for the US, ideally in Movement Disorders or Mental Health but also in speciality areas where expertise is required for infusions via portable pumps. We have the infrastructure and nurse care to support the home administration of this type of product. We will also consider late stage CNS/other specialist products either in phase 3 or in registration.